Evaluation of Agreements Between Managed Care Organizations and Providers of Community-Based Mental Illness and Addiction Disorder TreatmentsBySara Rosenbaum, JD,D. Richard Mauery, MPH,Joel Teitelbaum, LLM,Rita Vandivort-Warren, ACSWFebruary 1st 2002
"Trial" Prescriptions to Reduce Drug Wastage: Results From Canadian Programs and a Community Demonstration ProjectByJ. Michael Paterson MSc,Geoffrey M. Anderson, MD, PhDFebruary 1st 2002
Application of Pharmacoeconomics to Formulary Decision Making in Managed Care OrganizationsByDong-Churl Suh, PhD, MBA,Ijeoma R. N. Okpara, PharmD,Wendy B. Agnese, PharmD,Michael Toscani, PharmDFebruary 1st 2002
Comparison of Two Systems for Clinical Practice Profiling in Diabetic Care: Medical Records Versus Claims and Administrative DataByJ. Ross Maclean, MD,Donna M. Fick, RN, PhD,Wayne K. Hoffman, MD,Coleman T. King, MD,Eric R. Lough, MD,Jennifer L. Waller, PhDFebruary 1st 2002
A Comparison of Ambulatory Services for Patients with Managed Care and Fee-for-Service InsuranceByGeorge E. Kikano, MD,Clint W. Snyder, PhD,Edward J. Callahan, PhD,Meredith A. Goodwin, MS,Kurt C. Stange, MD, PhDFebruary 1st 2002
A New Method for Determining Patient Payments for Outpatient DrugsByDana P. Goldman, PhD,A. Mark Fendrick, MD,Dean G. Smith, PhD,Michael E. Chernew, PhDFebruary 1st 2002
